Yung‐Chia Kuo

ORCID: 0000-0003-1567-5169
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Head and Neck Cancer Studies
  • Metastasis and carcinoma case studies
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Viral-associated cancers and disorders
  • RNA modifications and cancer
  • Gastrointestinal Tumor Research and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Cancer Research and Treatments
  • Prostate Cancer Treatment and Research
  • Advanced Breast Cancer Therapies
  • Esophageal and GI Pathology
  • Fibroblast Growth Factor Research
  • Neuroendocrine Tumor Research Advances
  • Cancer Cells and Metastasis
  • Hepatitis C virus research
  • Virus-based gene therapy research
  • melanin and skin pigmentation
  • Dermatologic Treatments and Research
  • Wnt/β-catenin signaling in development and cancer

Chang Gung University
2015-2025

Chang Gung Memorial Hospital
2015-2025

Linkou Chang Gung Memorial Hospital
2014-2024

Taipei City Hospital
2021-2022

Eastern Cooperative Oncology Group
2015

Creative Commons
2015

Memorial Hospital
2015

Chiayi Chang Gung Memorial Hospital
2015

Keelung Chang Gung Memorial Hospital
2015

PURPOSE: This study assessed the impact of navify Tumor Board digital tool on multidisciplinary team tumor boards’ (MDTs) efficiency, comparing its streamlined workflow and preparation to conventional, time-consuming methods. METHODS: prospective observational (January–June 2021) compared MDT phase durations (preparation, discussion, follow-up) using platform versus conventional methods for integrated patient data management decision-making. RESULTS: The significantly improved efficiency...

10.3390/cancers17030444 article EN Cancers 2025-01-28

Background: Stage III gastric cancer is characterized by locally advanced disease with varying anatomic extent as measured the 7 th edition of American Joint Committee on Cancer (AJCC) staging system.There are no prognostic factors specifically identified in patients stage following extended lymph node dissection (D2) surgery.Materials and Methods: From 2007 to 2014, 534 underwent radical gastrectomy D2 at Chang Gung Memorial Hospital.Patients' characteristics impact adjuvant chemotherapy...

10.7150/jca.21989 article EN cc-by-nc Journal of Cancer 2017-11-28

This study aimed at investigating the ability of a preoperative Glasgow prognostic score (GPS) to predict postoperative complications and survival outcomes in patients with stage III gastric cancer undergoing D2 gastrectomy. We retrospectively reviewed data from 272 such patients, treated between 2010 2016, Taiwanese medical center. The were categorized according their GPS. In total, 36.8%, 48.5%, 14.7% assigned groups GPS 0, 1, 2, respectively. Overall surgical complication rates these 30%,...

10.3390/jcm8091448 article EN Journal of Clinical Medicine 2019-09-12

Determining the survival outcome for gastric cancer patients with metastases to more than 15 regional lymph nodes is difficult. This study aims develop a node metastatic ratio (LNR)-based prognostic model predict after D2 surgery in such patient groups. Our retrospectively enrolled 139 who underwent between 2007 and 2014. Clinicopathologic variables overall (OS) using multivariate Cox regression were selected create model. The predicting OS was developed based on five independent factors,...

10.1016/j.asjsur.2017.10.001 article EN cc-by-nc-nd Asian Journal of Surgery 2017-12-13

// Cheng-Lung Hsu 1 , Yung-Chia Kuo Yenlin Huang 2 Yin-Cheng 3 Kar-Wai Lui 4 Kai-Ping Chang 5 Tung-Liang Lin Hsien-Chi Fan An-Chi Chia-Hsun Hsieh Li-Yu Lee Hung-Ming Wang Hsin-Pai Li 6 Yu-Sun Division of Hematology-Oncology, Department Internal Medicine, Gung Memorial Hospital, University, Taoyuan 333, Taiwan, ROC Pathology, Neurologic Surgery, Medical Imaging and Intervention, Otolaryngology-Head Neck Cell Molecular Biology, Correspondence to: Hsu, e-mail: hsu2221@adm.cgmh.org.tw Keywords:...

10.18632/oncotarget.5544 article EN Oncotarget 2015-09-24

A previous study demonstrated that cytokeratin 19 (CK19) expression in hepatocellular carcinoma (HCC) is an indicator of HCC invasiveness, including lymph node metastasis (LNM), tumor infiltration/non-encapsulation and poor prognosis. The exact mechanism by which CK19 results prognosis remains unclear. Through the use Affymetrix U133A oligonucleotide microarray [20 patients with hepatitis B virus (HBV)-HCC], it was cadherin 17 (CDH17) significantly correlated (R2, 0.867; P<0.001) HBV-HCC....

10.3892/ol.2017.7320 article EN Oncology Letters 2017-11-01

Liver resection is a standard treatment for hepatocellular carcinoma (HCC).The purpose of this study was to investigate the clinicopathological characteristics and long-term outcomes octogenarians with HCC treated liver resection.Records patients who underwent were reviewed, older younger than 80 years compared.There 77 age or 3,309 years.Hepatitis C virus infection most common etiology among (43.1%), followed by non-viral causes (37.5%).The group had more co-morbidity but less hepatitis B...

10.18632/aging.101854 article EN cc-by Aging 2019-03-13

Differential overall survival of nasopharyngeal carcinoma (NPC) with different organ site metastases has been documented. Here, we attempted to determine the underlying mechanisms by assessing plasma and tumor tissue markers in relation patient survival. Pretreatment Epstein-Barr virus (EBV) DNA concentrations, cytokines macrophages, proliferation apoptosis were determined 178 patients metastatic NPC. The median (OS) was 19 months. Patients single had better outcomes than those multiple...

10.18632/oncotarget.10676 article EN Oncotarget 2016-07-18

Background: Nasopharyngeal carcinoma (NPC) involves host genetics, environmental and viral factors. In clinical observations, patients of young old ages were found to have higher recurrence metastatic rates. Methods: Cytokine array was employed screen druggable target(s). The candidate target(s) confirmed through patient-derived xenografts (PDXs) a new EBV-positive cell line, NPC-B13. Results: Overexpression epithelial growth factor (EGF) EGF receptor (EGFR) detected in than older patients....

10.3390/cancers13122954 article EN Cancers 2021-06-12

Paraneoplastic leukocytosis (PNL) in genitourinary cancer, though rare, can indicate aggressive behavior and poor outcomes. It has been potentially linked to cancer expressing G-CSF GM-CSF, along with their respective receptors, exerting an autocrine/paracrine effect. In our study, we successfully established four patient-derived xenograft (PDX) lines related cell from urothelial (UC), conducting next-generation sequencing (NGS) for genetic studies. UC-PDX-LN1, originating bladder exhibited...

10.62347/ihio5742 article EN American Journal of Cancer Research 2024-01-01

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer, and immune checkpoint inhibitors (ICIs) have shown efficacy in its treatment. The combination of chemotherapy ICIs represents a new trend the standard care for metastatic NPC. In this study, we aim to clarify cell profile related prognostic factors ICI-based treatment Programmed death ligand 1 (PD-L1) expression was measured 81 tissue samples that had not received prior ICI combined positive score (CPS) 58.0%...

10.62347/sspi9013 article EN American Journal of Cancer Research 2024-01-01

Abstract Objective Studies have rarely explored the efficacy of S‐1 in treating advanced pancreatic cancer outside Japan. This study compared survival outcomes patients with treated those without treatment before and after reimbursement was introduced Taiwan June 2014. Method We retrospectively analyzed 838 locally or metastatic who underwent palliative chemotherapy from 2010 to 2016 at 4 institutes Taiwan. For analysis, were categorized into two groups according whether they received as...

10.1002/cam4.2094 article EN cc-by Cancer Medicine 2019-04-18

Nasopharyngeal carcinoma (NPC) is associated with Epstein-Barr virus (EBV) infection. To test preclinical NPC drugs, we established two patient-derived xenograft (PDX) mouse models, EBV-positive PDX-B13 and EBV-negative PDX-Li41, for drug screening.Based on next generation sequencing (NGS) studies, had CCND1 copy number (CN) gain but CDKN2A CN loss, whereas PDX-Li41 RB1 TSC1 (negative regulator of mTOR) frameshift deletion mutation, increased activation mTOR, a serine/threonine kinase that...

10.1016/j.tranon.2023.101785 article EN cc-by-nc-nd Translational Oncology 2023-09-13

Progesterone analogues, such as megestrol acetate (MA) and medroxyprogesterone (MPA), have been used for the palliative care of cancer cachexia decades proven to increase body weight improve quality life performance status. The objective this study was determine effect progesterone analogue use on in terms pain control, status, gain, Epstein-Barr virus (EBV) DNA load recurrent/metastatic nasopharyngeal carcinoma (NPC) patients.

10.1016/j.bj.2017.06.006 article EN cc-by-nc-nd Biomedical Journal 2017-07-27

Carcinoma of unknown primary origin (CUP) is characterized by diverse histological subtypes and clinical presentations, ranging from clinically indolent to frankly aggressive behaviors. This study aimed identify prognostic factors CUP develop a simple risk model predict survival in cohort Asian patients.We retrospectively reviewed 190 patients diagnosed with between 2007 2012 at single medical center Taiwan. The clinicopathological parameters outcomes our were analyzed. A was developed using...

10.1097/md.0000000000002135 article EN cc-by-nc Medicine 2015-11-01

The association of non-hereditary (sporadic) gastrointestinal stromal tumors (GISTs) and second primary malignancies is known to be nonrandom, although the underlying molecular mechanisms remain unknown. In this study, 136 749 (18.1%) patients with sporadic GISTs were found have additional associated cancers, genitourinary/gynecologic/breast cancers being most prevalent. Gene mutations in their colorectal (CRCs) (n=9) analyzed using a panel 409 cancer-related genes, while separate group 40...

10.18632/oncotarget.12452 article EN Oncotarget 2016-10-04

This is a retrospective cohort study by analyzing multi-institutional electronic medical records database in Taiwan to compare long-term effectiveness and risk of major adverse cardiac events (MACE) chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with enzalutamide (ENZ) or abiraterone (AA). Patients aged 20 years older newly receiving androgen receptor targeted therapies ENZ AA from September 2016 December 2019 were included. We followed initiation...

10.1002/ijc.34348 article EN International Journal of Cancer 2022-11-08

4143 Background: The triplet regimen of S-1, leucovorin, oxaliplatin and gemcitabine (SLOG) has shown promising efficacy for metastatic pancreatic ductal adenocarcinoma (PDAC) in our previous study. Current multicenter randomized, phase II study compared the safety SLOG versus modified FOLFIRINOX (mFOLFIRINOX) patients with advanced/metastatic PDAC. Methods: Patients chemo-naïve, histologically confirmed PDAC, were randomly assigned to either (gemcitabine 800 mg/m 2 , fixed-rate infusion 85...

10.1200/jco.2021.39.15_suppl.4143 article EN Journal of Clinical Oncology 2021-05-20

Decisions regarding the staging, prognosis, and treatment of patients with head neck squamous cell carcinomas (HNSCCs) are made after determining their p16 expression levels human papillomavirus (HPV) infection status. We investigated prognostic roles p16-positive p16-negative circulating tumor cells (CTCs) counts in HNSCC patients. enrolled locally advanced HNSCCs who received definitive concurrent chemoradiotherapy for final analysis. performed CTC testing analysis before...

10.3390/jpm11111156 article EN Journal of Personalized Medicine 2021-11-07

Abstract Background Laparoscopic procedure has inherent merits of smaller incisions, better cosmesis, less postoperative pain, and earlier recovery. In the current study, we presented our method purely laparoscopic feeding jejunostomy compared its results with that conventional open approach. Methods We retrospectively reviewed patients from 2012 to 2019 who had received either (LJ, n = 29) or ones (OJ, 94) in Chang Gung Memorial Hospital, Linkou. Peri-operative data outcomes were analyzed....

10.1186/s12893-021-01050-4 article EN cc-by BMC Surgery 2021-01-13

Hepatitis often occurs after initiating immune checkpoint inhibitor (ICI) treatment. The time and grade of hepatitis ICI starts the prognostic role immune-related in patients with advanced hepatocellular carcinoma (aHCC) remain unclear.

10.2147/jhc.s464105 article EN cc-by-nc Journal of Hepatocellular Carcinoma 2024-10-01
Coming Soon ...